Waters (WAT) – Investment Analysts’ Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of Waters (NYSE: WAT) recently:

• 10/8/2026 – Waters was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
• 10/7/2026 – Waters had its price target raised by Barclays PLC from $460.00 to $500.00. They now have an “overweight” rating on the stock.
• 10/1/2026 – Waters had its price target raised by Guggenheim from $440.00 to $490.00. They now have a “buy” rating on the stock.
• 9/21/2026 – Waters had its price target raised by The Goldman Sachs Group, Inc. from $465.00 to $515.00. They now have a “buy” rating on the stock.
• 9/9/2026 – Waters was upgraded by UBS Group AG from “neutral” to “buy”. They now have a $490.00 price target on the stock, up from $375.00.
• 9/6/2026 – Waters was downgraded by Wall Street Zen from “buy” to “hold”.
• 8/29/2026 – Waters was upgraded by Wall Street Zen from “hold” to “buy”.
• 8/27/2026 – Waters was upgraded by Piper Sandler from “neutral” to “overweight”. They now have a $480.00 price target on the stock, up from $400.00.
• 8/12/2026 – Waters was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”.
• 8/10/2026 – Waters had its price target raised by Citigroup Inc. from $425.00 to $470.00. They now have a “buy” rating on the stock.

Insider Activity at Waters

In other news, Director Christopher Kuebler sold 3,626 shares of the stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $397.94, for a total value of $1,442,930.44. Following the completion of the sale, the director owned 17,808 shares of the company’s stock, valued at approximately $7,086,515.52. This represents a 16.92% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.31% of the company’s stock.

Get Waters Corporation alerts:

Waters Corporation (NYSE: WAT) develops and manufactures analytical workflow solutions used to measure, characterize and separate chemical and biological materials. Its customers include pharmaceutical and biotechnology companies, academic and government laboratories, and organizations in the industrial, food, environmental and other applied markets.

The company’s portfolio includes high-performance liquid chromatography and ultra-performance liquid chromatography systems, mass spectrometry instruments, chromatography columns and other laboratory consumables.

Read More

• Five stocks we like better than Waters
• Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
• Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
• Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
• Arista Networks Plugs Into All-Time Highs

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.